tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
UK Market

Alnylam Pharma (0HD2) Ratios

Compare
4 Followers

Alnylam Pharma Ratios

GB:0HD2's free cash flow for Q4 2025 was $0.76. For the 2025 fiscal year, GB:0HD2's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.76 2.76 2.78 3.08 3.51
Quick Ratio
2.71 2.71 2.71 2.99 3.34
Cash Ratio
1.13 1.13 0.81 0.84 1.13
Solvency Ratio
0.09 0.09 -0.05 -0.10 -0.29
Operating Cash Flow Ratio
0.36 0.36 >-0.01 0.11 -0.70
Short-Term Operating Cash Flow Coverage
0.00 0.00 -0.07 0.00 0.00
Net Current Asset Value
$ -126.49M$ -126.49M$ -877.61M$ -1.07B$ -1.01B
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.26 0.65 0.34 0.37
Debt-to-Equity Ratio
1.62 1.62 40.89 -5.92 -8.34
Debt-to-Capital Ratio
0.62 0.62 0.98 1.20 1.14
Long-Term Debt-to-Capital Ratio
0.56 0.56 0.97 1.28 1.18
Financial Leverage Ratio
6.29 6.29 63.20 -17.36 -22.41
Debt Service Coverage Ratio
1.83 2.17 -0.31 -2.19 -5.97
Interest Coverage Ratio
1.99 1.99 -1.25 -2.33 -5.03
Debt to Market Cap
0.02 0.02 0.08 0.04 0.04
Interest Debt Per Share
11.58 11.69 22.60 11.42 12.13
Net Debt to EBITDA
-0.80 -0.68 -9.94 -1.91 -0.49
Profitability Margins
Gross Profit Margin
81.72%81.77%85.62%83.02%83.73%
EBIT Margin
11.23%13.51%-10.48%-17.08%-93.60%
EBITDA Margin
12.73%15.00%-7.95%-14.12%-89.31%
Operating Profit Margin
13.51%13.51%-7.87%-15.43%-75.68%
Pretax Profit Margin
8.70%8.70%-16.79%-23.71%-108.63%
Net Profit Margin
8.45%8.45%-12.37%-24.08%-109.04%
Continuous Operations Profit Margin
8.45%8.45%-12.37%-24.08%-109.04%
Net Income Per EBT
97.09%97.09%73.71%101.55%100.37%
EBT Per EBIT
64.43%64.43%213.34%153.63%143.55%
Return on Assets (ROA)
6.32%6.32%-6.56%-11.49%-31.90%
Return on Equity (ROE)
90.35%39.76%-414.62%199.53%714.91%
Return on Capital Employed (ROCE)
14.33%14.33%-5.79%-9.86%-28.26%
Return on Invested Capital (ROIC)
13.74%13.74%-4.06%-9.72%-27.84%
Return on Tangible Assets
6.32%6.32%-6.56%-11.49%-31.90%
Earnings Yield
0.74%0.60%-0.93%-1.84%-3.91%
Efficiency Ratios
Receivables Turnover
4.78 4.78 5.55 5.58 4.36
Payables Turnover
5.87 5.85 3.66 5.59 1.72
Inventory Turnover
8.21 8.19 4.12 3.48 1.31
Fixed Asset Turnover
5.25 5.25 3.24 2.52 1.40
Asset Turnover
0.75 0.75 0.53 0.48 0.29
Working Capital Turnover Ratio
1.49 1.58 1.09 0.93 0.51
Cash Conversion Cycle
58.68 58.63 54.62 104.98 150.46
Days of Sales Outstanding
76.42 76.42 65.80 65.44 83.72
Days of Inventory Outstanding
44.47 44.59 88.62 104.82 278.83
Days of Payables Outstanding
62.21 62.37 99.80 65.28 212.09
Operating Cycle
120.89 121.00 154.42 170.26 362.55
Cash Flow Ratios
Operating Cash Flow Per Share
3.96 4.00 -0.07 0.83 -4.45
Free Cash Flow Per Share
3.52 3.55 -0.33 0.34 -5.04
CapEx Per Share
0.44 0.45 0.27 0.50 0.59
Free Cash Flow to Operating Cash Flow
0.89 0.89 5.12 0.40 1.13
Dividend Paid and CapEx Coverage Ratio
8.93 8.93 -0.24 1.67 -7.51
Capital Expenditure Coverage Ratio
8.93 8.93 -0.24 1.67 -7.51
Operating Cash Flow Coverage Ratio
0.41 0.41 >-0.01 0.08 -0.41
Operating Cash Flow to Sales Ratio
0.14 0.14 >-0.01 0.06 -0.52
Free Cash Flow Yield
1.10%0.89%-0.14%0.18%-2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
131.12 166.04 -107.99 -54.31 -25.57
Price-to-Sales (P/S) Ratio
11.11 14.03 13.36 13.08 27.88
Price-to-Book (P/B) Ratio
52.13 66.01 447.73 -108.36 -182.78
Price-to-Free Cash Flow (P/FCF) Ratio
88.66 111.94 -705.29 569.99 -47.15
Price-to-Operating Cash Flow Ratio
78.49 99.40 -3.61K 229.54 -53.43
Price-to-Earnings Growth (PEG) Ratio
0.20 -0.79 2.84 0.87 -0.88
Price-to-Fair Value
52.13 66.01 447.73 -108.36 -182.78
Enterprise Value Multiple
86.49 92.81 -177.89 -94.49 -31.70
Enterprise Value
42.00B 51.71B 31.81B 24.40B 29.37B
EV to EBITDA
88.86 92.81 -177.89 -94.49 -31.70
EV to Sales
11.31 13.92 14.15 13.35 28.31
EV to Free Cash Flow
90.25 111.12 -747.01 581.74 -47.89
EV to Operating Cash Flow
80.14 98.68 -3.83K 234.27 -54.27
Tangible Book Value Per Share
5.97 6.02 0.53 -1.77 -1.30
Shareholders’ Equity Per Share
5.97 6.02 0.53 -1.77 -1.30
Tax and Other Ratios
Effective Tax Rate
0.03 0.03 0.26 -0.02 >-0.01
Revenue Per Share
28.09 28.35 17.61 14.64 8.53
Net Income Per Share
2.37 2.39 -2.18 -3.52 -9.30
Tax Burden
0.97 0.97 0.74 1.02 1.00
Interest Burden
0.77 0.64 1.60 1.39 1.16
Research & Development to Revenue
0.36 0.36 0.50 0.55 0.85
SG&A to Revenue
0.24 0.00 0.43 0.44 0.74
Stock-Based Compensation to Revenue
0.07 0.09 0.12 0.12 0.22
Income Quality
1.67 1.67 0.03 -0.24 0.48
Currency in USD